Nair Vinay, Khaim Rafael, El-Salem Fadi, Kent Rebecca, Lerner Susan, Berger Amnon, Miko Leandra, Rollins Brett, Ebcioglu Zeynep, Delaney Veronica, Sehgal Vinita, Menon Madhav, Ames Scott, Benvenisty Alan, Wadhera Vikram, Arvelakas Antonious, Schiano Thomas, Rana Meena, Huprikar Shirish, Florman Sander, Shapiro Ron
Recanati/Miller Transplantation Institute, The Mount Sinai Medical Center, New York, NY.
Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY.
Clin Transpl. 2015;31:69-78.
Mount Sinai Hospital in New York has a long history in the field of organ transplantation. The first kidney transplant at Mount Sinai was performed in 1967 by the late Dr. Lewis Burrows and the first laparoscopic donor nephrectomy in New York was performed at Mount Sinai in 1996. Over 3000 kidney transplantations have been performed at Mount Sinai. In the early 1990s, the first hepatitis C virus (HCV) positive patient at Mount Sinai underwent a kidney transplant and the first kidney transplant in a patient with human immunodeficiency virus (HIV) in New York was performed at Mount Sinai in 2001. In general, these patients have done well after renal transplantation, with outcomes similar to those seen in non-infected patients. This chapter will describe the evolution of immunosuppressive regimens in HCV positive and HIV positive patients, and will describe the outcomes of kidney transplantation in these patients. Given the favorable outcomes, it is reasonable to continue to offer renal transplantation as a treatment for end stage renal disease patients with HCV and/or HIV.
纽约西奈山医院在器官移植领域有着悠久的历史。西奈山医院的首例肾移植手术于1967年由已故的刘易斯·伯罗斯医生完成,而纽约的首例腹腔镜供体肾切除术于1996年在西奈山医院进行。西奈山医院已完成了超过3000例肾移植手术。在20世纪90年代初,西奈山医院的首例丙型肝炎病毒(HCV)阳性患者接受了肾移植手术,2001年纽约首例人类免疫缺陷病毒(HIV)患者的肾移植手术也在西奈山医院进行。总体而言,这些患者肾移植术后情况良好,其结局与未感染患者相似。本章将描述HCV阳性和HIV阳性患者免疫抑制方案的演变,并阐述这些患者肾移植的结局。鉴于良好的结局,继续为患有HCV和/或HIV的终末期肾病患者提供肾移植治疗是合理的。